Manon C. Stam‐Slob

Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes

Suzanne E. Engelen, Yolanda van der Graaf, Manon C. Stam‐Slob et al. · International Journal of Cardiology · 2017 · 37 citations

Vascular Interventions, Diabetes Management, Diabetes Epidemiology +12

Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients

Manon C. Stam‐Slob, Frank L.J. Visseren, J. Wouter Jukema et al. · Clinical Research in Cardiology · 2016 · 34 citations · Full text

Cost-effectiveness of PCSK9 inhibition in addition to standard lipid-lowering therapy in patients at high risk for vascular disease

Manon C. Stam‐Slob, Yolanda van der Graaf, Anthonius de Boer et al. · International Journal of Cardiology · 2018 · 32 citations · Full text

Thrombosis, Hypertension, Cardiovascular Disease +11

Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients

Manon C. Stam‐Slob, Yolanda van der Graaf, Jacoba P. Greving et al. · Journal of the American Heart Association · 2017 · 22 citations · Full text

Effect of Type 2 Diabetes on Recurrent Major Cardiovascular Events for Patients With Symptomatic Vascular Disease at Different Locations

Manon C. Stam‐Slob, Yolanda van der Graaf, Gert J. de Borst et al. · Diabetes Care · 2015 · 20 citations